| 000 | 01414 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513112259.0 | ||
| 264 | 0 | _c19970314 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0090-4295 | ||
| 024 | 7 |
_a10.1016/s0090-4295(96)00445-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeikle, A W | |
| 245 | 0 | 0 |
_aProstate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. _h[electronic resource] |
| 260 |
_bUrology _cFeb 1997 |
||
| 300 |
_a191-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypogonadism _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProstate _xdrug effects |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aTestosterone _xadministration & dosage |
| 700 | 1 | _aArver, S | |
| 700 | 1 | _aDobs, A S | |
| 700 | 1 | _aAdolfsson, J | |
| 700 | 1 | _aSanders, S W | |
| 700 | 1 | _aMiddleton, R G | |
| 700 | 1 | _aStephenson, R A | |
| 700 | 1 | _aHoover, D R | |
| 700 | 1 | _aRajaram, L | |
| 700 | 1 | _aMazer, N A | |
| 773 | 0 |
_tUrology _gvol. 49 _gno. 2 _gp. 191-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(96)00445-1 _zAvailable from publisher's website |
| 999 |
_c9026069 _d9026069 |
||